Knowledge is our power. Science is our tool.

Mr. Peters is an experienced executive having co-founded four start-up companies in the past 15 years. Mr. Peters has raised over $1.0 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4.0 billion on sale. Mr. Peters previously was Chief Financial Officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

More than 25 years of experience as a lawyer and executive in diverse industries. Current Chair of the Board of Crescent Point Energy Corp. Has served as an executive in several customer-centric and diverse industries, as EVP, Corporate Services and General Counsel for WestJet Airlines Ltd., the Assistant General Counsel, Upstream at Imperial Oil Ltd., and the Senior Vice President, Legal/IP & General Counsel, Corporate Secretary for SMART Technologies Inc. A member of the Institute of Corporate Directors and has extensive corporate governance experience. Holds a Bachelor of Commerce, Finance degree and a Bachelor of Laws degree, both from the University of Calgary. Admitted to the Law Society of Alberta in 1991 and holds the ICD.D designation.

Mr. Foreman has over 20 years of professional experience in private equity, corporate finance, and financial technology. Mr. Foreman is currently a Partner and the Chief Investment Officer of Tuatara Capital, L.P. Prior to co-founding Tuatara Al was a Managing Director at Highbridge Principal Strategies, and earlier was a Managing Director at J.P. Morgan in the Financial Sponsors Group and Private Equity Fund Services business. Previously, Al held executive roles at Vitech Systems Group and Virtual Growth, and he began his career at Citigroup. Mr. Foreman earned a B.S. in Finance from the University of Connecticut and a dual J.D./MBA from Arizona State University.

Mr. Lalani has been Chief Financial Officer of Kelt Exploration Ltd. since October 2012 and Vice President since October 2017. Before that, Mr. Lalani was Chief Financial Officer & Vice President, Finance of Celtic Exploration Ltd. from October 2002 to February 2013. He has over 25 years’ experience in leadership positions. Mr. Lalani holds a Bachelor of Commerce degree from the University of Calgary.

Mr. Archibald is an independent businessman; President of Cypress Energy Corp., a private investment company, since March 2008.  Mr. Archibald also serves on the board and various committees of Palisade Capital, Panorama Mountain Resort, Petronas Energy Canada, Spartan Delta Corp., Serafina Energy Ltd., and Willow Biosciences.  He has been involved in the formation of numerous companies as well as serving in an executive and director capacity in a number of private and public companies as well as not for profit entities.  He currently also serves on the board of Winsport.   Mr Archibald has an MBA from the Ivey Business School and a BComm. from the University of Alberta.

Dr. Kalantzis has been co-founder of several public companies in his 25 years’ experience and is currently the President and CEO of Spartan Delta Corp. Dr. Kalantzis has been instrumental in a number of significant transactions including in his capacity as a senior officer with Spartan Energy Corp. from December 2013 to May 2018, Spartan Oil Corp. from June 2011 to January 2013, Spartan Exploration Ltd. (public) from September 2010 to June 2011 and Spartan Exploration Ltd. (private) from January 2008 to September 2010. Dr. Kalantzis holds an MSc from the University of Saskatchewan and a PhD from the University of Alberta and has published and presented many papers in international journals and conferences.

Dr. Seufer-Wasserthal has more than 25 years’ experience in the biotechnology industry. He was previously Chief Commercial Officer at Sestina Bio, LLC and Chief Business Officer of Origenis GmbH and served in various business development roles at Intrexon, Codexis and Evotec. Dr. Seufer Wasserthal received his PhD from the Technical University of Graz in Austria and published widely in the then starting field of synthetic biology.

With more than 30 years experience, Dr. Jim Lalonde has led highly performing biotech R&D teams at Altus Biologics, Codexis and Inscripta.  As R&D lead at Codexis, his team develop the best-in-class CodeEvolver® Protein Engineering technology combining machine learning, protein modeling, HTP expression, and assay and NGS to create enzymes for biocatalysis, oral enzyme replacement therapies, nutrition, and diagnostics. His team developed and commercialized processes to more than 25 pharmaceutical actives, including blockbusters such as Lipitor®, Januvia®, and Paxlovid® and were recognized with three U.S. Presidential Green Chemistry Awards.  He now applies his experience as a scientific advisory to several start-ups.  Jim has a PhD in Organic Chemistry from Texas A&M University and an Honours BSc from Lakehead University.